Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C

*Department of Pharmaceutical Outcomes and Policy, College of Pharmacy

†Center for Drug Evaluation and Safety, University of Florida, Gainesville, FL

Research reported in this publication was supported by grant K01DA045618 and R01DA044985 from the National Institute on Drug Abuse of the National Institutes of Health (NIH) and R21AG060308 from the NIH/National Institute of Aging. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Arizona Medicaid data was obtained from the Center for Health Information and Research at Arizona State University via an interinstitutional data use agreement.

The authors declare no conflict of interest.

Correspondence to: Haesuk Park, PhD, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, 1225 Center Drive HPNP Building, Room 3325, Gainesville, FL 32610. E-mail: [email protected].

留言 (0)

沒有登入
gif